Allarity Therapeutics, Inc.
ALLR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001860657
No open-market purchases or sales by Allarity Therapeutics, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Allarity Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 4 | 9 | +5 |
| Shares | 38.8K | 510.4K | +471.6K (+1,215.7%) |
| Value | $11.7K | $107.8K | +$96.1K (+823.1%) |
New holders (7)
Institutions that held Allarity Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 265,338 | $56.0K | 0.00% |
| Geode Capital Management, LLC | 102,328 | $21.8K | 0.00% |
| Jump Financial, LLC | 38,795 | $8.26K | 0.00% |
| HRT Financial LP | 34,691 | $7.00K | 0.00% |
| Jane Street Group, LLC | 15,667 | $3.33K | 0.00% |
| Bank of America Corp | 145 | $31 | 0.00% |
| Headlands Technologies LLC | 20 | $4 | 0.00% |
Sold out (2)
Institutions that held Allarity Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Wells Fargo & Company | 36 | $11 |
| Morgan Stanley | 7 | $2 |